CPT Code 11103: Tangential skin biopsy billing guide 2026

Key takeaways

CPT 11103 is an add-on code for each additional tangential skin biopsy lesion beyond the first.

It cannot be billed without its primary code, CPT 11102, on the same claim.

Add-on codes are exempt from modifier 51, while modifiers 59 and XS separate distinct lesion sites.

Medicare pays less for 11103 than for 11102, so check current rates in the CMS fee schedule.

Practice management software like Pabau keeps biopsy documentation and claim submission inside one patient record.

What CPT 11103 covers

CPT code 11103 describes a tangential biopsy of skin for each separate additional lesion beyond the first. It is an add-on code, so it cannot be submitted without its parent code, CPT 11102. Dermatology and primary care practices report this pair when a tangential biopsy covers more than one lesion in a single encounter.

In 2019, the American Medical Association replaced the old single biopsy code with three technique-specific pairs. CPT 11103 sits in the tangential pair alongside 11102. Code selection follows the technique documented in the note. A shave, a punch, and an incisional biopsy each carry their own primary and add-on code.

Official descriptor and the biopsy code family

The AMA rewrote this descriptor in 2019, and the current wording names the technique directly. “Tangential biopsy of skin (e.g., shave, scoop, saucerization, curettage); each separate/additional lesion (List separately in addition to code for primary procedure).”

The instruction to list it separately is what most denials on this code come back to. Dermatology EMR software that carries the parent code through to the claim keeps that pairing intact.

Code selection depends on the biopsy technique, not the diagnosis. A provider who shave-biopsies three lesions bills 11102 once and 11103 twice. If that provider also punch-biopsies a fourth lesion, it needs its own primary code, 11104, and its own add-on chain.

What is a tangential biopsy?

A tangential biopsy removes tissue with a blade passed parallel to the skin surface. It samples the epidermis and part of the superficial dermis, without creating a full-thickness wound. Practitioners still call it a shave biopsy, and the AMA’s 2019 wording also covers scoop and saucerization.

Recording the technique word for word matters more than it looks. Skin clinic software that pre-populates biopsy fields keeps the note and the code speaking the same language.

Choosing the wrong biopsy family is the most consequential error in this code set. If the note documents a shave but the claim reports 11104, the record and the code disagree. That mismatch is exactly what payer audits look for.

Tangential biopsy is also easy to confuse with shave removal, which is a different code family entirely. Removal codes such as 11302 and 11311 describe taking a lesion off, not sampling it. If the intent was removal rather than diagnosis, the biopsy codes do not apply.

CPT 11103 vs 11102: Key differences

CPT 11102 reports the first tangential biopsy lesion and covers the baseline work. CPT 11103 captures each later lesion taken by the same technique in the same encounter. Neither code carries the encounter on its own once multiple lesions are involved.

When three tangential lesions are biopsied, the claim reads 11102 x 1 and 11103 x 2. The unit count for 11103 is always the total number of tangential lesions minus one.

Reimbursement and fee schedule for 2026

Reimbursement for CPT 11103 varies by setting, payer, and locality. Because it is an add-on code, its relative value units sit below those of the primary code. The CMS Physician Fee Schedule lookup tool is the authoritative source for current Medicare rates by locality. Check it before you submit, because CMS updates the schedule every year.

Important: The range above is an industry estimate built from aggregated fee schedule data. Actual Medicare payment depends on the 2026 conversion factor, the geographic practice cost indices, and the final CMS rule. Verify every rate through the CMS lookup before you submit.

Modifiers that apply to CPT 11103

Add-on codes follow modifier rules of their own. CPT 11103 sits in the AMA’s modifier 51 exempt list, so appending modifier 51 is incorrect and invites a rejection.

Confirm modifier preferences with each payer before you submit. Some commercial plans follow National Correct Coding Initiative edits closely and prefer the granular X modifiers over modifier 59. AAPC’s code lookup shows which NCCI edits apply, which beats waiting for a denial to tell you.

Solid HIPAA-compliant documentation at the point of service also supports the modifier during a payer review. The note has to show two anatomically distinct sites, not just two units on a claim line.

ICD-10 codes that support medical necessity

Medical necessity for a tangential biopsy rests on the diagnosis code attached to the claim. The diagnosis has to support the clinical rationale for taking tissue. A generic skin code with no documented suspicion invites a medical necessity denial. A CPT-to-ICD-10 crosswalk tool can confirm payer coverage policies before you submit.

These are commonly cited examples rather than an exhaustive medical necessity guide. Payer local coverage determinations (LCDs) set out which ICD-10 codes support coverage for skin biopsies. Check the applicable determinations first, especially for Medicare Advantage plans that apply stricter criteria.

Documentation requirements

Weak documentation is the second most common cause of 11103 denials, after incorrect pairing. The procedure note has to stand on its own as justification for every lesion biopsied.

Digital intake forms that capture biopsy-specific fields at the point of care keep that record complete. Standardized medical forms hold the format steady whichever provider performs the biopsy.

• Biopsy technique documented: The note must state that a tangential or shave technique was used, not a generic biopsy performed. A note that says punch biopsy cannot support 11103.
• Site identification per lesion: Record each lesion’s anatomical location separately, such as right cheek or left forearm. A reference to multiple lesions does not substantiate multiple units.
• Lesion count and size: Record how many lesions were biopsied and, where relevant, the approximate size of each one.
• Specimen disposition: Note where each specimen went, such as pathology for histological examination, and track the specimen number against its lesion.
• Clinical indication: Record why the biopsy was taken, whether that is a suspected diagnosis, a change in appearance, or a patient complaint.
• Provider identity: The note must carry the name and credentials of the provider who performed the biopsy.

Billing multiple lesions in one encounter

The stacking rule is simple once the formula is clear. Report 11102 once for the primary lesion, then 11103 once for each additional tangential lesion. No ceiling applies to how many times 11103 can be reported in one encounter. Each unit still needs its own documented lesion in the procedure note.

1. Count the total tangential lesions biopsied during the encounter.
2. Bill 11102 x 1 for the first lesion.
3. Bill 11103 for every lesion after the first.
4. Confirm each 11103 unit maps to a separately documented biopsy site.
5. If a lesion in the same encounter was taken by punch, open 11104 as a new primary. Add 11105 for each further punch lesion.

Some payers apply quantity edits to 11103, flagging claims above four units for review. When you bill high unit counts, send the records with the claim or expect a request for them.

Common billing mistakes

Most 11103 denials trace back to a handful of repeatable errors. Compliance management tools catch them before submission rather than after the denial arrives, and a structured pre-submission check does the same job by hand.

• Billing 11103 without 11102: The most common denial trigger. An add-on code cannot stand alone on a claim, so 11102 always leads when a tangential biopsy is performed.
• Appending modifier 51: Add-on codes are modifier 51 exempt by AMA definition. Appending it flags the claim for manual review and often ends in a reduction or a denial.
• Wrong biopsy family: Billing 11103 when the note documents a punch technique creates a mismatch that surfaces in audits. Code selection follows the documented technique, not the intended one and not the diagnosis.
• Unbundling with destruction codes: CPT 11103 generally cannot be billed with a destruction code such as 17000 for the same lesion in the same session. Biopsy and destruction of one lesion are treated as bundled.
• Missing lesion-specific documentation: Claiming several units of 11103 without separate site notes is a documentation failure rather than a coding one. The outcome is identical, either a denial or a recoupment.
• Incorrect ICD-10 pairing: A diagnosis that does not support the reason for the biopsy can trigger a medical necessity denial. That happens even when the CPT coding itself is correct.

Related codes for skin biopsy procedures

CPT 11103 sits inside a wider set of skin procedure and pathology codes. Knowing the neighbors prevents cross-code errors and captures everything billable from a biopsy encounter. The same primary-plus-add-on pattern turns up elsewhere in dermatology, including 11043 for debridement measured by area.

How Pabau supports dermatology biopsy billing

Dermatology practices billing tangential biopsy codes run a chain from the procedure note to the claim. Detail drops out at every handover. Pabau is an all-in-one practice management system, so the clinical note, the specimen record, and the invoice sit on one patient file.

When a clinician records a tangential biopsy of three lesions, the billing team can see the technique, the lesion count, and where each specimen went. Structured medical records mean nobody reconstructs that from paper or a second system.

Pabau’s claims management software then runs a completeness check on each claim before it goes out. It confirms that the details insurers need, such as membership numbers and authorization codes, are present. It does not validate CPT pairings for you, so the add-on rules in this guide still sit with your coder.

For groups running several locations, one shared record structure keeps every provider’s biopsy documentation in the same format. That makes an audit response faster to assemble and easier to defend.

Keep biopsy notes and claims in one system

Pabau records biopsy technique, site, and specimen details in the patient file, then carries those details into the claim. Your billing team works from the clinical note instead of chasing it.

Book a demo

Conclusion

Get the pairing right and 11103 stops being a problem code. The rules are few, and every one of them is settled before the claim leaves your practice.

The judgment worth keeping is that this is a documentation question dressed up as a billing one. Payers do not argue about whether 11103 exists. They argue about whether your note proves a second lesion was sampled by the same technique.

Fix the note and the claim takes care of itself. Book a demo to see how Pabau keeps biopsy documentation and claim submission on one patient record.

Continue your research

Choosing software for a skin practice? Best dermatology EHR software compares the systems that handle clinical notes and insurance billing together.

Need the consent paperwork to match? Dermatology consent template gives you a form patients can sign before a biopsy.

New to insurance workflows? What is medical billing walks through the path from invoice to payment.

Weighing up how to structure the practice? Group vs private practice sets out what changes for billing and staffing.

Want the intake side tightened up? Dermatology intake form captures history and lesion concerns before the appointment starts.

Frequently asked questions